183 Overcoming immunotherapy resistance in T cell-inflamed lung cancer
Main Authors: | Brendan Horton, Duncan Morgan, Noor Momin, Vidit Bhandarkar, Dane Wittrup, Chris Love |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
by: Brendan L. Horton, et al.
Published: (2023-10-01) -
1011 The signal strength of signal 2 and 3 during T cell priming affect the functional fate of an anti-tumor T cell response
by: Stefani Spranger, et al.
Published: (2023-11-01) -
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
by: Ming Yi, et al.
Published: (2021-09-01) -
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
by: Tianye Li, et al.
Published: (2024-03-01) -
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
by: Kang, Byong H, et al.
Published: (2021)